A Short Term Cost-Effectiveness Model For Oral Antidiabetic Medicines in Europe

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.3, 1998-03, pp. : 317-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe

By MacKeigan L.D.

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 709-714

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of Thrombolytics: A Simplified Model

By Rabuş Şule lzzettin Fikret Sancar Mesut Rabuş Murat Kırma Cevat Yakut Cevat

Pharmacy World and Science, Vol. 27, Iss. 3, 2005-06 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia

By Lindgren P.

PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model

By Yao Guiqing

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 879-889

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra O’Brien Judith A Salas Maribel

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite